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High level of TGF-β1 induces expression 
of CatL. (A) Levels of Tgfb1, Ctsl, and con-
trol gene in glomeruli of TGF-β1 Tg and 
WT animals. Phenotype categorization 
is as described previously (23). (B) H&E-
stained sections of the renal cortex, show-
ing increased CatL staining in TGF-β1 Tg 
mice. Kidneys of WT and TGF-β1 Tg mice 
were stained for CatL using anti–cytosolic 
CatL antibody, and nuclei were stained 
using DAPI. (C) CatL staining levels in sec-
tions from B. ***P < 0.001. (D) H&E-stained 
sections showing dendrin localization in the 
nucleus of the podocytes in TGF-β1 Tg ani-
mals (arrows). Kidneys of WT and TGF-β1 
mice were stained for dendrin using anti-
dendrin antibody. (E) Dendrin staining 
levels in sections from D. ***P < 0.001. 
(F and G) H&E-stained sections showing 
increased CatL staining in glomerulus of 
3-week-old Cd2ap–/– mice (arrows). Kid-
neys of WT and Cd2ap–/– mice were 
stained for CatL using anti–cytosolic CatL 
antibody, and nuclei were stained using 
DAPI. (H) Dendrin localization in glomeru-
lus of WT and Cd2ap–/– mice at different 
stages of development. WT1 was used to 
stain podocyte nuclei (red). In the young 
glomerulus, dendrin (green) was localized 
at the membrane (ribbon staining pattern), 
without any colocalization with WT1. At 
4 weeks, dendrin staining was still localized 
to the plasma membrane in WT mice, but 
was predominantly found in the nucleus 
costaining with WT1 in Cd2ap–/– mice. Scale 
bars: 20 μm (B, D, F, and G); 30 μm (H).
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that  increased exogenous  levels of TGF-β1 can  increase both 
endogenous kidney TGF-β1 levels and CatL expression.
It has previously been shown that high levels of TGF-β1 induce 
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Prolonged loss of CD2AP leads to expression of cytosolic CatL. (A) 
Actin cytoskeleton and FA organization in fully differentiated low- 
and high-Tgfb1 Cd2ap–/– cells. Note the loss of well-defined stress 
fibers and dramatic increase in number of transverse arcs in high-
Tgfb1 Cd2ap–/– cells. FAs and F-actin were visualized with anti-paxil-
lin antibodies and rhodamine-phalloidin, respectively. (B) Low-Tgfb1 
Cd2ap–/– podocytes could be transformed into high-Tgfb1 Cd2ap–/– 
podocytes by high TGF-β1 levels. WT and low-Tgfb1 Cd2ap–/– pas-
sage cells were treated with 5 ng/ml TGF-β1 in the media for 24 hours. 
Actin cytoskeleton was monitored by staining cells with rhodamine-
phalloidin, and dendrin localization was monitored using anti-dendrin 
antibody (green). (C–E) mRNA levels for Tgfb1 (C) and Ctsl (D and 
E), determined by RT-PCR in podocytes. When indicated, cells were 
treated with 5 ng/ml TGF-β1 for 24 hours or with 50 μM LPS for 24 
hours. Podocytes expressing Actn4 mutant are also shown in E. (F) 
Subcellular fractionation of low- and high-Tgfb1 Cd2ap–/– podocytes 
in isotonic sucrose. Total proteins from soluble (S) and particulate (P) 
fractions were probed for CatL and for the lysosomal protein markers 
Lamp-2 and mannosidase (Manno), then analyzed by Western blot-
ting. GAPDH was used as a loading control. Strong cytosolic CatL 
induction (asterisk) was observed in both soluble and pellet fractions 
of high-Tgfb1 Cd2ap–/– podocytes. Scale bars: 20 μm.
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Cytosolic CatL activity regulates actin cytoskeleton in Cd2ap–/– cells. (A) Ctsl mRNA levels, determined by RT-PCR, in high-Tgfb1 Cd2ap–/– 
podocytes infected with different shRNA constructs (C2, C5, C6) downregulating endogenous CatL. Con, high-Tgfb1 Cd2ap–/– podocytes not 
infected with lentiviruses; Scr, cells infected with lentiviruses expressing a scrambled oligo. (B) CatL levels in high-Tgfb1 Cd2ap–/– podocytes 
infected with lentiviruses expressing different shRNA constructs to downregulate CatL at relative volumes as indicated. (C) Time course of CatL 
activity in high-Tgfb1 Cd2ap–/– podocytes and in high-Tgfb1 Cd2ap–/– podocytes infected with lentiviruses to downregulate CatL in the absence 
and presence of CA074 at neutral pH. (D) Time course of CatL activity in the presence of CA074 in high-Tgfb1 Cd2ap–/– podocytes, high-Tgfb1 
Cd2ap–/– podocytes infected with lentiviruses to downregulate CatL, and WT podocytes at neutral pH. (E and F) Protein levels in WT cells, high-
Tgfb1 Cd2ap–/– podocytes, and high-Tgfb1 Cd2ap–/– podocytes treated with E64 or infected with lentiviruses to downregulate CatL (shRNA-C6). 
Dyn, dynamin; Synpo, synaptopodin. GAPDH was used as a loading control. (G) Quantitation of protein levels from Western blots in E and F.
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Number of FAs within WT podocytes and high-Tgfb1 Cd2ap–/– 
podocytes with CatL downregulation by diverse treatments. 
(A) Organization of the actin cytoskeleton and FAs in podo-
cytes in which CatL was downregulated. FAs and F-actin 
were visualized with anti-paxillin and rhodamine-phalloidin, 
respectively. (B) Quantitation representing measurements of 
>50 cells shown in A. Data are mean ± standard deviation. 
***P < 0.001. Scale bars: 20 μm.
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Prolonged CD2AP loss leads to dendrin translocation into the nucle-
us. (A) Ddn mRNA levels, determined by RT-PCR, in high-Tgfb1 
Cd2ap–/– podocytes infected with different shRNA constructs (D2–D4) 
downregulating endogenous dendrin. Con, uninfected high-Tgfb1 
Cd2ap–/– podocytes; Scr, high-Tgfb1 Cd2ap–/– podocytes infected 
with lentiviruses expressing a scrambled oligo. (B) Dendrin levels in 
high-Tgfb1 Cd2ap–/– podocytes infected with lentiviruses expressing 
the 2 most efficient shRNA constructs, D3 and D4. (C) Organization of 
the actin cytoskeleton and FAs in high-Tgfb1 Cd2ap–/– podocytes with 
dendrin downregulation. FAs and F-actin were visualized with anti-pax-
illin and rhodamine-phalloidin, respectively. (D) Number of FAs within 
WT and high-Tgfb1 Cd2ap–/– podocytes with dendrin downregulation. 
Data (mean ± standard deviation) represent measurements of >50 
cells in C. ***P < 0.001. (E) Ctsl mRNA levels, determined by RT-
PCR, in high-Tgfb1 Cd2ap–/– podocytes with dendrin downregulation. 
(F) Protein levels of CatL, dynamin, synaptopodin, RhoA, and GAPDH 
in high-Tgfb1 Cd2ap–/– podocytes and cells infected with lentiviruses. 
(G) Time course of CatL activity in high-Tgfb1 Cd2ap–/– podocytes, 
high-Tgfb1 Cd2ap–/– podocytes infected with lentiviruses, and low-
Tgfb1 Cd2ap–/– podocytes at neutral pH. (H) Loss of CD2AP rendered 
podocytes hypersensitive to proapoptotic signals, as shown by specific 
enrichment of mono- and oligonucleosomes released into the cyto-
plasm of WT and high-Tgfb1 Cd2ap–/– podocytes treated with different 
apoptosis inducers. Stauro, staurosporine; Actino D, actinomycin D; 
Angio II, angiotensin II. (I) TGF-β1–induced apoptosis was reversed by 
downregulation of CatL or dendrin in high-Tgfb1 Cd2ap–/– podocytes. 
Scale bars: 20 μm.
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Dendrin is a transcription factor of CatL. (A and B) Nuclear dendrin induced transcription from the CatL promoter, but not from the CatB promoter. 
HEK 293 cells were cotransfected with pSEAP reporter vector containing the promoter of interest, dendrin, and Metridia luciferase to normal-
ize for transfection efficiency. Mutant dendrin lacking its nuclear localization signal (dNLS) was ineffective. Promoter activity and response to 
dendrin depended on a region between bp –1,215 and bp –339, as revealed by partial deletion promoter constructs. ***P < 0.001. (C) Strategy 
used to identify the dendrin binding site within the CatL promoter. The promoter fragment between bp –1,215 and –339 was divided into 4 parts. 
EMSA with these unlabeled DNA fragments, visualized by SYBR green, revealed dendrin binding to fragment F (data not shown), which was 
then further divided into overlapping fragments to fine-map the dendrin binding site. (D) EMSA demonstrating specific dendrin binding to one 
of the biotin-labeled 60-bp oligonucleotides that were completely abolished by a 200-fold excess of unlabeled oligonucleotide. (E) The 60-bp 
oligonucleotide that exhibited dendrin binding was divided into 3 overlapping 24-bp oligonucleotides to further narrow the dendrin binding site. 
Mutation of 3 nucleotides in the 5′ region, but not in the central or 3′ region, of the 24-bp oligonucleotide 4-1 completely abolished dendrin binding, 
as demonstrated by the inability of a 200-fold excess of unlabeled mutated oligonucleotide to compete with the labeled WT oligonucleotide.
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Cytosolic CatL proteolytically processes CD2AP in podocytes. (A) 
Immunoblot of cleaved CD2AP fragments tagged with N-terminal GFP. 
At pH 7.0, CD2AP cleaved into a stable 55-kDa fragment (squares), as 
detected with anti-GFP antibody. We detect the same fragment with the 
N-CD2AP antiserum. This antiserum also detected a weak band corre-
sponding to a 44-kDa fragment (triangle). (B) Match of cleavage frag-
ments with predicted CatL cleavage site QPLGS. (C) Deletion of the 
CatL cleavage site LSAAE protected CD2AP from limited proteolysis 
into p32 (circle). (D) Match of p32 with predicted CatL cleavage site 
LSAAE. (E) CatL cleaved CD2AP-FLAG, yielding p32 (circle), detected 
by anti–C-CD2AP. (F) WT Ctsl cleaved CD2AP in HEK 293 cells. 
Cytosolic CatL (CatL M1) was sufficient to cleave CD2AP, yielding p32 
(circle). These cleavage reactions were prevented by incubation of the 
cells with E64. (G) Coimmunoprecipitation of nephrin, synaptopodin, 
and dendrin from HEK 293 cells transfected with full-length CD2AP, 
N-terminal CD2AP, and p32. (H) Structural domains of CD2AP, 
together with major CatL cleavage sites, predicted sizes of resulting 
fragments from CatL digestion, and recognition sites of the antibodies 
used. SH3, src homology domain 3; PR, proline-rich motif; CC, coiled-
coil domain. (I) Immunofluorescent staining of kidney biopsies from 
patients with MCD and FSGS. N-terminal CD2AP was reduced only in 
progressive disease (i.e., FSGS). Scale bar: 30 μm.
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particles  in HEK 293T  cells. We used  a  target  set  of  3  clones with 






















































Signaling between nucleus and cytoplasm of healthy and injured podocyte and SDs are mediated by CatL.
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Purification of CD2AP and dendrin. FLAG-CD2AP and FLAG-dendrin were 
expressed in HEK 293 cells, immobilized on anti-FLAG M2 agarose (Sigma-
Aldrich), and eluted with FLAG peptide (Sigma-Aldrich).
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misdirected  filtration  and  peritubular  filtrate 
spreading in nephrons with segmental glomerulo-
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